Pidotimod powder Api, USP

We are offering high quality of Pidotimod Api. We are known for manufacturing, exporting, distributing, trading and supplying Pidotimod Api in Gujarat, India. Further, this is safely packaged by our professionals in diverse packaging options that maintain its purity and effectiveness. Shreeji Pharma International is leading Manufacturer, Exporter, Distributor, and Supplier Pidotimod Api in Gujarat. India. Shreeji Pharma International manufacturing & gmp; supplying all products under GMP site with all types of regulatory supports. Shreeji Pharma International is the largest manufacturer, Exporter and supplier of Pidotimod Api. Nowadays Shreeji Pharma International is one of the leading manufacturer and exporter, who are manufacturing Pidotimod Api as well as Intermediates of Pidotimod Api. Shreeji Pharma International is exporter, supplier, distributor and manufacturers of the Active Pharmaceuticals Ingredients in many countries for many years. Shreeji Pharma International currently exports Pidotimod Api to countries like Gulf Countries, South East Asia countries, African Countries, CIS Countries, LATAM countries, Central American Countries and in European countries. 1. General Information: Chemical Name: Pidotimod CAS Number: 121808-62-6 Molecular Formula: C9H12N2O4S Molecular Weight: 244.27 g/mol IUPAC Name: (R)-3-(S)-3-oxo-1,2-thiazolidine-4-carboxylic acid, 2-acetamido- 2. Properties & Appearance: Physical Form: White or almost white crystalline powder Solubility: Soluble in water, slightly soluble in ethanol, practically insoluble in most organic solvents pH (1% solution): 3.5 - 5.5 Purity: Typically ≥ 99% (by HPLC) Storage Conditions: Store in a cool, dry place away from direct sunlight 3. Pharmacological Profile: Therapeutic Category: Immunomodulator Mode of Action: Enhances innate and adaptive immunity Increases T-cell and macrophage activity Stimulates production of cytokines and antibodies Indications: Treatment of recurrent respiratory tract infections Immunostimulation in pediatric and geriatric patients Adjunct therapy for chronic bronchitis and COPD 4. Manufacturing & Quality Control: Production Method: Chemical synthesis Quality Standards: Complies with pharmacopoeial standards (EP, USP, or in-house specifications) Heavy metals: ≤ 10 ppm Residual solvents: Within ICH limits Microbial limits: Free from bacterial and fungal contamination 5. Applications & Formulations: Used in oral formulations such as: Tablets (100 mg, 200 mg) Capsules Syrups & Oral Solutions (for pediatric use) 6. Safety & Precautions: Adverse Effects: Generally well-tolerated, but may cause mild gastrointestinal discomfort or skin reactions in rare cases. Contraindications: Hypersensitivity to pidotimod or excipients in the formulation. Pregnancy & Lactation: Limited data available; use only if clearly necessary. About the Company GST Registration Date: 2017 Legal Status of Firm: Partnership Number of Employees: Upto 10 People Annual Turnover: 25 - 100 Cr